Market Tracker

04/29 5:16pm ET

Mylan NV (NASDAQ:MYL)

41.71
Delayed Data
As of Apr 29
 -0.89 / -2.09%
Today’s Change
37.59
Today|||52-Week Range
75.26
-22.86%
Year-to-Date

Today’s Trading

Previous close42.60
Today’s open42.37
Day’s range41.31 - 42.73
Volume7,688,093
Average volume (3 months)5,690,106
Market cap$20.9B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+14.31%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+21.91%
P/E ratio18.0
Price/Sales2.84
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-2.41-2.78%
ZTSZoetis Inc-0.16-0.34%
PRGOPerrigo Company PLC+0.22+0.23%
BMRNBiomarin Pharmaceuti...-0.42-0.49%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.76
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts